Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.25
+0.03002.46%
Volume:104.60K
Turnover:128.14K
Market Cap:62.27M
PE:-1.12
High:1.33
Open:1.21
Low:1.19
Close:1.22
Loading ...
Feb 15, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 12, 2023

Major Issues Report

8-K - Current report
Dec 02, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2022

Major Issues Report

8-K - Current report
Sep 13, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2022

Major Issues Report

8-K - Current report
Jun 03, 2022

Major Issues Report

8-K - Current report
Jun 02, 2022

Major Issues Report

8-K - Current report
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Major Issues Report

8-K - Current report
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 14, 2022

Major Issues Report

8-K - Current report
Feb 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals